FDA Inspection 783661 — Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC — FEI 3002733956

The FDA completed an inspection of Fresenius Kabi USA, LLC on May 4, 2012 in Lake Zurich, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 4, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lake Zurich, IL (United States)

Citations

IDCFRDescription
670621 CFR 310.305(c)(1)(i)Late submission
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report
683221 CFR 314.80(c)(2)Late submission of annual safety reports